Comparing two nerve block techniques for pain management after shoulder surgery
Pericapsular Nerve Block Versus Interscalene Nerve Block for Acute Pain Management in Shoulder Arthroscopy: A Randomized Controlled Study
This study is testing which of two different nerve block methods can help people manage pain better after shoulder surgery.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 44 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Kafrelsheikh University Academic / other |
| Locations | 1 site (Kafr Ash Shaykh, Kafrelsheikh) |
| Trial ID | NCT05788367 on ClinicalTrials.gov |
What this trial studies
This study aims to compare the effectiveness of the pericapsular nerve block (PENG) and the interscalene nerve block (ISB) for managing postoperative pain following shoulder arthroscopy. Shoulder arthroscopy is a common orthopedic procedure that often results in significant postoperative pain, necessitating effective pain control methods. The study will evaluate the outcomes of these two regional anesthesia techniques to determine which provides better pain relief and fewer side effects compared to traditional opioid medications. Participants will be monitored for pain levels and any adverse reactions to the nerve blocks used.
Who should consider this trial
Good fit: Ideal candidates for this study are patients with a body mass index under 40 and classified as ASA physical status I-II, scheduled for elective shoulder arthroscopy.
Not a fit: Patients with known allergies to local anesthetics or all opioid medications, as well as those with chronic opioid use or coagulopathy, may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved pain management strategies for patients undergoing shoulder arthroscopy, reducing reliance on opioids.
How similar studies have performed: Previous studies have shown success with similar regional anesthesia techniques, indicating potential for effective pain management.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Body mass index \< 40 kg/m2 * American Society of Anesthesiologists (ASA) physical status I-II * posted for elective shoulder arthroscopy Exclusion Criteria: * Known allergy to local anesthetics * allergy to all opioid medications * diagnostic shoulder arthroscopic procedures * patients with chronic opioids use and coagulopathy
Where this trial is running
Kafr Ash Shaykh, Kafrelsheikh
- Mohammed Fouad Mohamed Algyar — Kafr Ash Shaykh, Kafrelsheikh, Egypt (Recruiting)
Study contacts
- Principal investigator: Mohammed F Algyar, MD — Lecturer of Anaesthesiology, Surgical Intensive Care and Pain Medicine, Faculty of Medicine, Kafrelsheikh University
- Study coordinator: Mohammed F Algyar, MD
- Email: mohammad.algaiar@med.kfs.edu.eg
- Phone: 00201111645345
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.